Natural Health Trends (NASDAQ:NHTC) Releases Quarterly Earnings Results

Natural Health Trends (NASDAQ:NHTC) announced its quarterly earnings data on Wednesday. The company reported ($0.05) earnings per share for the quarter, FiscalAI reports. The firm had revenue of $9.75 million during the quarter. Natural Health Trends had a negative net margin of 2.22% and a negative return on equity of 3.08%.

Here are the key takeaways from Natural Health Trends’ conference call:

• Fourth-quarter revenue was $9.7 million, a 3% sequential increase but a 10% decline year-over-year, suggesting short-term stabilization amid ongoing pressure versus 2024.
• Management cited growth in key international markets (Taiwan, Peru, Japan, Colombia) and a 10% full-year increase in sales of curated product bundles, indicating sustained member engagement and product demand.
• Restructuring actions are substantially complete—including relocating about 40% of sourcing to East Asia and office/workforce optimization—with an expected significant portion of approximately $1.5 million in annualized cost savings to be realized in 2026.
• The company reported a fourth-quarter net loss of $588,000 (‑$0.05 per diluted share) and used $6.0 million of cash in operations for the year, with operating results negatively impacted by inventory write-offs and restructuring charges.
• The board remains committed to returning capital—having paid $9.2 million in 2025 dividends, ending the year with $28.9 million in cash, equivalents, and marketable securities, and declaring a quarterly $0.10 per-share dividend payable Feb 27.

Natural Health Trends Price Performance

NASDAQ NHTC traded up $0.16 on Friday, hitting $3.86. 11,759 shares of the company were exchanged, compared to its average volume of 34,722. Natural Health Trends has a twelve month low of $2.40 and a twelve month high of $6.00. The firm has a market capitalization of $44.43 million, a P/E ratio of -48.24 and a beta of 0.85. The company’s 50 day moving average price is $3.36 and its 200-day moving average price is $3.94.

Natural Health Trends Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 27th. Shareholders of record on Tuesday, February 17th will be issued a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a yield of 10.4%. The ex-dividend date is Tuesday, February 17th. Natural Health Trends’s payout ratio is presently -1,000.00%.

Institutional Investors Weigh In On Natural Health Trends

Large investors have recently made changes to their positions in the company. Osaic Holdings Inc. boosted its stake in Natural Health Trends by 536,392.2% in the 2nd quarter. Osaic Holdings Inc. now owns 413,099 shares of the company’s stock worth $1,789,000 after purchasing an additional 413,022 shares during the period. Bridgeway Capital Management LLC acquired a new stake in shares of Natural Health Trends in the third quarter worth $101,000. Finally, CIBC Bancorp USA Inc. purchased a new position in shares of Natural Health Trends during the third quarter valued at $718,000. Institutional investors and hedge funds own 10.13% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of Natural Health Trends in a report on Wednesday, December 24th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has an average rating of “Sell”.

Natural Health Trends Company Profile

Natural Health Trends Corp. is a U.S.-based holding company that develops, markets and distributes a range of plant-based health supplements, nutritional products and personal care items. The company’s product portfolio spans weight management, skin care, men’s health, nutritional supplements and wellness solutions designed to support overall health and beauty. Natural Health Trends focuses on delivering scientifically formulated products through modern e-commerce channels and direct selling platforms.

Through its principal subsidiaries in the People’s Republic of China—including Shanghai NHTC Health Products Co, Ltd.